News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,086 Results
Type
Article (5010)
Company Profile (17)
Press Release (220059)
Section
Business (82198)
Career Advice (461)
Deals (15041)
Drug Delivery (8)
Drug Development (19061)
Employer Resources (30)
FDA (3676)
Job Trends (3900)
News (120100)
Policy (7501)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (292)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14768)
ALS (19)
Alzheimer's disease (247)
Antibody-drug conjugate (ADC) (11)
Approvals (3693)
Artificial intelligence (40)
Autoimmune disease (3)
Automation (2)
Bankruptcy (97)
Best Places to Work (2862)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (48)
Cancer (442)
Cardiovascular disease (22)
Career advice (392)
Career pathing (2)
CAR-T (31)
Cell therapy (102)
Cervical cancer (2)
Clinical research (16022)
Collaboration (165)
Compensation (168)
Complete response letters (2)
COVID-19 (301)
CRISPR (7)
C-suite (101)
Cystic fibrosis (16)
Data (507)
Depression (5)
Diabetes (41)
Diagnostics (2040)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40795)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37737)
Executive appointments (310)
FDA (3924)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (181)
Gene editing (15)
Generative AI (2)
Gene therapy (50)
GLP-1 (108)
Government (411)
Guidances (16)
Healthcare (5035)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (317)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7822)
IRA (3)
Job creations (1120)
Job search strategy (360)
Kidney cancer (6)
Labor market (4)
Layoffs (100)
Leadership (5)
Legal (2332)
Liver cancer (17)
Lung cancer (54)
Lymphoma (29)
Management (10)
Manufacturing (48)
MASH (27)
Medical device (3858)
Medtech (3859)
Mergers & acquisitions (7424)
Metabolic disorders (120)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (338)
NextGen: Class of 2025 (1674)
Non-profit (727)
Northern California (916)
Now hiring (2)
Obesity (53)
Opinion (30)
Ovarian cancer (17)
Pain (12)
Pancreatic cancer (14)
Parkinson's disease (26)
Partnered (4)
Patents (21)
Patient recruitment (28)
Peanut (5)
People (24582)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4775)
Phase II (6957)
Phase III (5547)
Pipeline (543)
Policy (9)
Postmarket research (625)
Preclinical (1868)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (67)
Real estate (1874)
Recruiting (8)
Regulatory (5111)
Reports (14)
Research institute (301)
Resumes & cover letters (68)
Rett syndrome (3)
Schizophrenia (21)
Series A (26)
Series B (22)
Sickle cell disease (7)
Southern California (694)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (3)
Startups (1007)
Stomach cancer (1)
Supply chain (10)
Tariffs (3)
United States (6970)
Vaccines (36)
Venture capitalists (2)
Weight loss (21)
Women's health (1)
Date
Today (45)
Last 7 days (122)
Last 30 days (719)
Last 365 days (10028)
2025 (2907)
2024 (11027)
2023 (13193)
2022 (18658)
2021 (19678)
2020 (18238)
2019 (13206)
2018 (10205)
2017 (10001)
2016 (9156)
2015 (12118)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11446)
Australia (1608)
California (1922)
Canada (693)
China (70)
Colorado (82)
Connecticut (91)
Delaware (29)
Europe (24492)
Florida (268)
Georgia (33)
Idaho (23)
Illinois (112)
India (6)
Indiana (63)
Iowa (1)
Japan (68)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (220)
Massachusetts (1538)
Michigan (85)
Minnesota (138)
Mississippi (1)
Missouri (22)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (15)
New Jersey (555)
New Mexico (5)
New York (469)
North Carolina (325)
North Dakota (2)
Northern California (916)
Ohio (55)
Oklahoma (5)
Oregon (3)
Pennsylvania (340)
Puerto Rico (1)
Rhode Island (13)
South America (276)
South Carolina (5)
Southern California (694)
Tennessee (39)
Texas (227)
Utah (59)
Virginia (45)
Washington D.C. (9)
Washington State (173)
West Virginia (2)
Wisconsin (21)
225,086 Results for "dynatronics corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Dynatronics Corporation Reports Second Quarter Results
Dynatronics Corporation today announced that the company will release financial results for its second quarter of fiscal year 2023 on Thursday, February 9, 2023 before the market opens.
January 26, 2023
·
2 min read
Business
Dynatronics Corporation Reports Second Quarter Fiscal Year 2023 Financial Results and Business Highlights
Dynatronics Corporation today reported financial results for its second quarter of fiscal year 2023 ended December 31, 2022, and provided an update on the business.
February 9, 2023
·
7 min read
BioMidwest
Dynatronics Corporation Announces Reverse Stock Split - Feb 01, 2023
Dynatronics Corporation, a leading manufacturer of athletic training, physical therapy, and rehabilitation products, announced that it will effect a 1-for-5 reverse stock split of its outstanding common stock, effective at 5:00 p.m. on February 1, 2023.
February 1, 2023
·
3 min read
Business
Dynatronics Corporation Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Business Highlights
Dynatronics Corporation, a leading manufacturer of athletic training, physical therapy, and rehabilitation products, reported financial results for its fourth quarter and fiscal year ended June 30, 2022, and provided an update on recent business highlights.
September 22, 2022
·
9 min read
Business
Dynatronics Corporation Reports Second Quarter Financial Results and Business Highlights
Dynatronics Corporation today reported financial results and business highlights for its second quarter of fiscal year 2022 for the period ended December 31, 2021.
February 10, 2022
·
9 min read
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
BioMidwest
Dynatronics Corporation Announces Participation in Upcoming Investor Conferences
Dynatronics Corporation today announced that management will participate in two upcoming investor conferences to provide an update on recent business highlights. LD Micro Main Event on October 13, 2021
October 12, 2021
·
2 min read
Business
Dynatronics Announces Appointment of New Chief Information Officer; Krier to add Chief Financial Officer Responsibilities
Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced changes to its management team.
July 6, 2022
·
4 min read
Press Releases
Quantum BioPharma Corporate Update
April 21, 2025
·
4 min read
Business
Dynatronics Corporation Reports Third Quarter Results
Dynatronics Corporation, a leading manufacturer of athletic training, physical therapy, and rehabilitation products, announced financial results for its third quarter of fiscal year 2021 for the period ended March 31, 2021.
May 13, 2021
·
11 min read
1 of 22,509
Next
